Risk Management in Biologics Technology Transfer.

Robert Toso, Jonathan Tsang,Jasmina Xie,Stephen Hohwald, David Bain,Derek Willison-Parry

PDA journal of pharmaceutical science and technology(2016)

引用 23|浏览0
暂无评分
摘要
Technology transfer of biological products is a complex process that is important for product commercialization. To achieve a successful technology transfer, the risks that arise from changes throughout the project must be managed. Iterative risk analysis and mitigation tools can be used to both evaluate and reduce risk. The technology transfer stage gate model is used as an example tool to help manage risks derived from both designed process change and unplanned changes that arise due to unforeseen circumstances. The strategy of risk assessment for a change can be tailored to the type of change. In addition, a cross-functional team and centralized documentation helps maximize risk management efficiency to achieve a successful technology transfer.
更多
查看译文
关键词
Biopharmaceutical processes,Risk management,Technology transfer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要